By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY The U.S. Food and Drug Administration granted accelerated approval for Pirtobrutinib (Jaypirca) to be administered to adult patients diagnosed with chronic lymphocytic leukemia (CLL) or small
We spoke with the organizers and speakers of our GI oncology conference to learn about their experience
MoreWe spoke with oncologists about treatment plans, advancements, and key facts about head and neck cancers
MoreWe spoke with oncologists and surgeons about treatment plans, advancements and key facts about testicular cancer
MoreLearn more about how our SABCS Highlights conference went from our organizers and speakers
MoreHear updates about our cancer hospital in Nepal from the doctors that work there
MoreOur volunteer spotlight for April is on Sriyansh Shah! We spoke with him about his interest in oncology and fundraising goals.
MoreMeet our education committee members that help organize all the great conferences
MoreOur March volunteer spotlight is on Dr. Brahman Konda! He spoke with us about his interest in the foundation and global health.
MoreWe spoke with experts about kidney cancer treatments, advancements, and interesting facts
More